S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Aromatherapy spray linked to US deaths faces recall

Friday, October 22, 2021 | Mike Stobbe, AP Medical Writer

Trump visits CDC for coronavirus update
In this Friday, March 6, 2020, file photo, the headquarters for Centers for Disease Control and Prevention is shown in Atlanta, Georgia. U.S. health officials said Friday, Oct. 22, 2021, they may have solved the mystery of how four people in different states came down with a deadly tropical disease, even though none had traveled internationally. (AP Photo/Ron Harris, File)

NEW YORK (AP) — U.S. health officials may have solved the mystery of how four people in different states came down with a serious tropical disease even though none had traveled internationally: an aromatherapy spray imported from India.

The Centers for Disease Control and Prevention said Friday that investigators found the same type of bacteria that causes the disease, melioidosis, in a spray bottle found in one of the patients' homes.

The four people were from Georgia, Kansas, Minnesota and Texas. Two of them, one a child in Georgia, died.

The agency said it was testing to confirm the bacteria in the bottle is the same strain as that seen in the four patients. It previously said lab analyses showed all four infections were closely related.

The spray found in the Georgia patient's home was made in India. The genetic profile of the bacteria in the bottle is similar to that of strains usually found in South Asia, the agency said.

The contaminated product is labeled “Better Homes & Gardens Lavender & Chamomile Essential Oil Infused Aromatherapy Room Spray with Gemstones,” the CDC said. It was sold for $4 in 55 Walmart stores and on Walmart’s website starting in February and until Thursday.

The Consumer Product Safety Commission and Walmart issued a recall Friday for 3,900 bottles of the spray in six scents. Officials are investigating whether other scents and brands may pose a risk.

Walmart issued a statement Friday, saying the company took immediate action when federal agencies told the retailer of their findings.

Melioidosis is a rare in the United States, with about 12 cases reported annually. People can get it through direct contact with contaminated soil and water. The CDC said the infection is treatable if caught early and treated correctly.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Should you invest $1,000 in Walmart right now?

Before you consider Walmart, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walmart wasn't on the list.

While Walmart currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Walmart (WMT)3.0$144.90-1.1%1.52%40.82Buy$170.39
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.